NEOGENOMICS INC — Director's Dealing 2011

May 2, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2011-05-02

Reporting Person: DENT MICHAEL T (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	60537	Direct
Common Stock	1666170	Indirect
Common Stock	24000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$0.25	2014-08-13	Common Stock (400000)		Direct
Warrant (Right to Buy)	$1.5	2012-06-06	Common Stock (100000)		Direct

Footnotes

F1: On April 27, 2011 the Board of Directors approved and granted a restricted stock award of 24,000 shares of NeoGenomics common stock. The terms of the award call for 2,000 shares to vest on the last day of the next 12 quarters starting on June 30, 2011 as long as Mr. Dent remains a Director of the Company.